Eli Lilly and Company
Antibodies that bind TGF-Alpha and Epiregulin for use in the treatment of pain

Abstract:

The present invention provides for therapeutic use of antibodies that bind human TGF-alpha and human Epiregulin in the treatment of chronic pain, and in particular chronic osteoarthritis pain, chronic diabetic neuropathy pain, or chronic low back pain.